Drug Royalty III LP 1’s Senior Secured Notes Offering
December 20, 2018
Cravath represented Drug Royalty III LP 1 in connection with its $100 million Rule 144A senior secured notes offering. Drug Royalty III LP 1 is a special purpose limited partnership that owns assets related to pharmaceutical products. The transaction closed on December 7, 2018.
The Cravath team included partner Nicholas A. Dorsey, senior attorney Elizabeth Albert and associates Randall F. Limberg and Samuel A. Lifton on securities matters; partner David J. Kappos, practice area attorney Anthony N. Magistrale and associate Joel Feigenbaum on intellectual property matters; and associate Arvind Ravichandran on tax matters. Seann E. Archibald also worked on securities matters.
Related Practices & Industries
People
- Photo
-
-
J.D., 2009, Cornell Law SchoolOrder of the Coif, summa cum laude
-
M.Acc., 2006, Case Western Reserve Universitysumma cum laude
-
B.S., 2006, Case Western Reserve Universitysumma cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 1987, Yale Law Schoolwith Honors
-
A.B., 1984, Harvard Collegecum laude
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
December 01, 2025
Polaris Inc.’s Registered Senior Notes Offering
Cravath represented the underwriters in connection with the $500 million registered senior notes offering of Polaris Inc. Polaris Inc. designs, engineers, manufactures and markets powersport vehicles and also designs and manufactures or sources parts, garments and accessories. The transaction closed on November 13, 2025.
Deals & Cases
December 01, 2025
The Mosaic Company’s Registered Senior Notes Offering
Cravath represented the underwriters in connection with the $900 million registered senior notes offering of The Mosaic Company, the world’s leading producer and marketer of concentrated phosphate and potash crop nutrients. The transaction closed on November 13, 2025.
Deals & Cases
November 26, 2025
Howmet Aerospace Inc.’s Registered Senior Notes Offering
Cravath represented the underwriters in connection with the $500 million registered notes offering of Howmet Aerospace Inc., a leading global provider of advanced engineered solutions for the aerospace and transportation industries. The transaction closed on November 12, 2025.
Deals & Cases
November 18, 2025
Ripple Labs, Inc.’s Private Placement of Class A Common Stock
Cravath represented funds managed by affiliates of Brevan Howard in connection with an investment in Ripple Labs, Inc., consisting of a private placement of Class A Common Stock, as part of Ripple’s $500 million strategic investment at a $40 billion valuation, led by funds managed by affiliates of Fortress Investment Group, affiliates of Citadel Securities, Pantera Capital, Galaxy Digital, Brevan Howard and Marshall Wace. The transaction closed on November 4, 2025.
